维普中文期刊产品整合服务
17篇 您的检索式:作者名="DUBERTRET M L"
    题名 作者 年代 出处 被引量
1Efficacy and safety of mizolastine 10 mg in a placelbo-controlled with loratadine in chronic idiopathic urticaria:results of the MILOR Study显示文摘Dubertret L Murrieta Aguttes M Tonet J 1999J EIlr Acad Dermatol Venereol1999,12,1:1
2Efficacy and safety of mizo- lastine 10 mg in a placebo - controlled comparison with loratadine in chronic idiopathic urticaria : results of the MILOR Study 显示文摘Dubertret L Murrieta Aguttcs M Tonet J 1999J Eur Acad Dermatol Veuereol1999,12,1:1
3Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with lorata dine in chronic idiopathic urticaria: results of the MILOR Study显示文摘Dubertret L Murrieta Aguttes M Toner J 1999J Eur Acad Dermatol Venereol1999,12,1:1
4Mizolastine in primary acquired cold urticaria 显示文摘Dubertret L Pecquet C Murrieta Aguttes M 2003J Am Acad Dermatol2003,48,4:1
5Effect of human basic fibroblast growth factor on fibroblast proliferation,cell volume,collagen lattice contraction:in comparison with the acidic type显示文摘IMAIZUMI T JEAN-LOUISs F DUBERTRET M L 1996J Dermatol Sci1996,11,2:1
6Mizolastine in primary acquired cold urticaria 显示文摘Dubertret L Pecquet C Murrieta-Aguttes M et d 2003J Am Acad Dermatol2003,48,4:1
7Efficacy and safety of mizolastine 10mg in placebo-controlled comparison with loratadine in chronic idiopathic urticaria显示文摘 Murrieta Aguttes M 1999Journal of the European Academy of Dermatology and Venereology1999,12,:1
8UV-A-induced AP-1 activation requires the Raf/ERK pathway in human NCTC 2544 keratinocytes显示文摘Djavaheri-Mergny M Dubertret L 2001Exp Dermatol2001,10,3:1
9Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study显示文摘Dubertret L Murrieta Aguttes M Tonet J 1999J Eur Acad Dermatol Venereol1999,12,1:1
10Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study 显示文摘Dubertret L Murrieta Aguttes M Tone J 1999Eur Acad Dermatol Venercol1999,12,1:1
11Mizolastine in primary acquired cold urticaria显示文摘Dubertret L Pecquet C Murrieta-Aguttes M et ol 2003J Am Acad Dermatol2003,48,4:1
12Mizolastine in primary acquired cold urticaria 显示文摘DUBERTRET L PECQUET C MURRIETA-AGUTTES M 2003J Am Acad Dermatol2003,48,4:1
13Efficacy and safety of mizo- lastine 10 mg in a placebo-controlled comparison with loratadine in chro- nic idiopathicurticaria : results of the MILOR Study 显示文摘Dubertret L Murrieta Aguttes M Tonet J 1999J Eur Acad Der- matol Venereol1999,12,1:1
14Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study显示文摘 Murrieta Aguttes M Tonet J 1999J Eur Acad Dermatol Venereol1999,12,1:1
15Foxp3 expressing CD4^+CD25^high regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells显示文摘Viguier M Lemaitre F Verola O Cho MS Gorochov G Dubertret L 2004J Immunol2004,173,2:1
16FoxP3 expressing CD4 + CD25 (high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T ceils显示文摘Viguier M Lemaitre F Verola O Cho MS Gorochov G Dubertret L 2004J Immunol2004,173,2:1
17Malassezia folliculitis:characteristics and therapeutic response in 26 patients显示文摘Lévy A Feuilhade de Chauvin M Dubertret L 2007Ann Dermatol Venereol2007,134,11:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费